JPMorgan Starts Regeneron Pharma (REGN) at Neutral
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $897.76 -0.38%
Rating Summary:
29 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 14 | New: 16
Rating Summary:
29 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 14 | New: 16
Join SI Premium – FREE
JPMorgan initiates coverage on Regeneron Pharma (NASDAQ: REGN) with a Neutral. PT $60.00.
For more ratings news on Regeneron Pharma click here and for the rating history of Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $55.43 yesterday.
For more ratings news on Regeneron Pharma click here and for the rating history of Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $55.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $1,099 at UBS
- Janney Starts Vistra Energy (VST) at Buy
- JPMorgan Upgrades JetBlue Airways (JBLU) to Neutral, 'second least-liked airline based on sellside rating'
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
